Stay Informed
Stories

Quiz: Did You Review Pfizer’s 2023 Impact Report?

April 8, 2024

"*" indicates required fields

In March, Pfizer released it’s 2023 Impact Report, which demonstrates the company's dedication to its Environmental, Social and Governance (ESG) priority areas and advancing progress towards sustainability goals.

“It reflects our dedication to being a force for good in the world by acting with integrity, holding ourselves to high standards, being accountable to our commitments, and addressing shortcomings candidly and with specific plans for improvement,” said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer.

Pfizer's ESG efforts align with the company's commitment to achieving its Purpose – breakthroughs that change patients' lives.

Did you check out Pfizer’s 2023 Impact Report? Quiz your knowledge below!

Pfizer’s approach to ESG includes six priority areas that are aligned with the company’s Purpose. Which of the following are among the six priorities?*
In 2023, approximately how many people around the world were treated with and / or vaccinated by a Pfizer product?1*
What initiative did Pfizer launch in 2023 to support patient advocacy organizations around the world by empowering them with knowledge and skills through offering evidence-based tools and resources that elevate their work with patient communities?*
As part of Pfizer’s commitment to achieve the voluntary Net Zero standard, by what year does the company aim to reduce its greenhouse gas (GHG) emissions by 95% and its value chain emissions by 90% from 2019 levels?*
By what year does Pfizer plan to achieve the goal of sourcing 100% renewable energy, as part of the company's commitment to achieve the voluntary Net Zero standard?*
What percentage of Pfizer New Molecular Entity and novel biologic applications approved by the U.S. Food and Drug Administration between 2019-2023 were designated as Breakthrough Therapies?*
In December 2023, Pfizer completed an acquisition with the goal of delivering breakthroughs that improve the lives of people with cancer. Which company did Pfizer acquire in December 2023?*
True or false, Pfizer was named one of the World's Most Ethical Companies by Ethisphere for the third year in a row?*

1 The Patients Treated metric is calculated from Pfizer and third-party datasets. This metric excludes data from Seagen Inc., which was acquired by Pfizer in December 2023. Figures may be limited given the coverage provided by external sources (e.g., calendar duration, geographic and product coverage) and are subject to change. Numbers are estimates and in some cases use global volume, daily dosage and number of treatment days to facilitate calculations. Methodologies to calculate estimates may vary by product type given the nature of the product and available data. Patients taking multiple Pfizer products may be counted as multiple patients towards total. Numbers do not include comprehensive estimated patient counts from Ex-US Access & Affordability programs (this does not include An Accord for a Healthier World). Historical estimates may periodically be subject to revision due to restatements in the underlying data source.

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at www.pfizer.com. and the SEC’s website at www.sec.gov. Please also refer to our 2023 Impact Report, which is available on our website at www.pfizer.com..

Join Pfizer Investor Insights

Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts.

I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy.